Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

5.65
0.0000
Post-market: 5.700.0500+0.88%17:01 EST
Volume:3.53M
Turnover:19.66M
Market Cap:644.10M
PE:-3.89
High:5.79
Open:5.40
Low:5.24
Close:5.65
52wk High:6.16
52wk Low:1.60
Shares:114.00M
Float Shares:102.00M
Volume Ratio:1.91
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4506
EPS(LYR):-1.2306
ROE:-37.26%
ROA:-17.24%
PB:2.66
PE(LYR):-4.59

Loading ...

Perspective Therapeutics Initiated at Overweight by Piper Sandler

Dow Jones
·
Feb 19

Perspective Therapeutics initiated with an Overweight at Piper Sandler

TIPRANKS
·
Feb 19

Perspective Therapeutics Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $16

THOMSON REUTERS
·
Feb 19

Perspective Therapeutics (CATX) Receives a Buy from JonesTrading

TIPRANKS
·
Feb 18

Perspective Therapeutics Inc. to Report Full Year 2025 Financial Results and Provide Business Update

Reuters
·
Feb 17

Buy Rating on Perspective Therapeutics (CATX) Driven by Differentiated Radiopharmaceutical Platform and Undervalued Long-Term Upside

TIPRANKS
·
Feb 17

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX)

TIPRANKS
·
Feb 13

Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline

TIPRANKS
·
Feb 04

Perspective Therapeutics Raises $175 Million in Stock and Pre-Funded Warrant Offering

Reuters
·
Feb 02

Perspective Therapeutics Inc - Prices 39,576,088 Shares at $3.79 Each

THOMSON REUTERS
·
Feb 02

Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Feb 02

Perspective Therapeutics Inc - Net Proceeds to Advance Clinical Development and Invest in Facilities

THOMSON REUTERS
·
Feb 02

Perspective Therapeutics Highlights Progress in Radiopharmaceutical Pipeline

TIPRANKS
·
Feb 02

Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
Jan 30

Perspective Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $12 From $10

THOMSON REUTERS
·
Jan 30

Perspective Therapeutics (CATX) Gets a Buy from Wedbush

TIPRANKS
·
Jan 13

Perspective Therapeutics Price Target Maintained With a $14.00/Share by BTIG

Dow Jones
·
Jan 13

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Myriad Genetics (MYGN)

TIPRANKS
·
Jan 13

Perspective Therapeutics outlines 2026 clinical and manufacturing priorities

TIPRANKS
·
Jan 12

Perspective Therapeutics Announces Plans to Advance Clinical Pipeline, Expand Manufacturing Capacity, and Present Updated Data at 2026 Medical Conferences

Reuters
·
Jan 12